MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Medical University of Graz
Graz, AustriaPublicaciones en colaboración con investigadores/as de Medical University of Graz (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477